Sarepta Therapeutics, Inc. (SRPT)
NASDAQ·Healthcare·Biotechnology
$21.12
+0.67%
Mkt Cap $2.17B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $369.60M | $442.93M | +19.84% | -$1.03 | -$3.58 | -247.57% | — | — |
| Q4 2025 Nov 3, 2025 | $391.35M | $399.36M | +2.04% | $0.01 | -$0.13 | -1400.00% | — | — |
| Q3 2025 Aug 6, 2025 | $342.94M | $611.09M | +78.19% | $1.11 | $2.02 | +81.98% | — | — |
| Q2 2025 May 6, 2025 | $739.59M | $744.86M | +0.71% | $0.35 | -$3.42 | -1077.14% | — | — |
| Q1 2025 Feb 26, 2025 | $631.03M | $658.41M | +4.34% | $1.38 | $1.50 | +8.70% | — | — |
| Q4 2024 Nov 6, 2024 | $407.17M | $467.17M | +14.74% | -$0.06 | $0.62 | +1139.75% | — | — |
| Q3 2024 Aug 7, 2024 | $394.38M | $362.93M | -7.98% | $0.01 | $0.07 | +1201.12% | — | — |
| Q2 2024 May 1, 2024 | $379.52M | $413.46M | +8.94% | $0.10 | $0.73 | +625.65% | — | — |
| Q1 2024 Feb 28, 2024 | $385.81M | $396.78M | +2.84% | $0.01 | $0.47 | +3084.28% | — | — |
| Q4 2023 Nov 1, 2023 | $363.15M | $331.82M | -8.63% | -$1.66 | -$0.46 | +72.29% | — | — |
| Q3 2023 Aug 2, 2023 | $259.55M | $261.24M | +0.65% | -$1.89 | -$0.27 | +85.71% | — | — |
| Q2 2023 May 2, 2023 | $241.96M | $253.50M | +4.77% | -$1.46 | -$0.97 | +33.56% | — | — |
| Q1 2023 Feb 28, 2023 | $250.40M | $258.43M | +3.21% | -$1.28 | -$1.24 | +3.13% | — | — |
| Q4 2022 Nov 2, 2022 | $234.52M | $230.27M | -1.81% | -$1.21 | -$2.94 | -142.98% | — | — |
| Q3 2022 Aug 2, 2022 | $220.81M | $233.49M | +5.74% | -$1.07 | -$2.65 | -147.66% | — | — |
| Q2 2022 May 4, 2022 | $206.43M | $210.83M | +2.13% | -$1.35 | -$1.20 | +11.11% | — | — |
| Q1 2022 Mar 1, 2022 | $197.97M | $201.46M | +1.76% | -$1.51 | -$1.42 | +5.96% | — | — |
| Q4 2021 Nov 3, 2021 | $285.94M | $189.41M | -33.76% | -$1.86 | -$0.60 | +67.74% | — | — |
| Q3 2021 Aug 4, 2021 | $162.65M | $164.09M | +0.88% | -$1.03 | -$1.02 | +0.97% | — | — |
| Q2 2021 May 5, 2021 | $149.16M | $146.93M | -1.49% | -$2.01 | -$2.10 | -4.48% | — | — |